• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects.

作者信息

Sadoul J L, Chécler F, Kitabgi P, Rostène W, Javoy-Agid F, Vincent J P

出版信息

Biochem Biophys Res Commun. 1984 Nov 30;125(1):395-404. doi: 10.1016/s0006-291x(84)80381-2.

DOI:10.1016/s0006-291x(84)80381-2
PMID:6095844
Abstract

Monoiodo [125I-Tyr3]-Neurotensin binding was studied in post mortem substantia nigra from 17 control and 15 parkinsonian subjects. Binding to individual homogenates was decreased by 58%, 49% and 26% at 0.36, 1.4, 5.5 M(-9) concentration of ligand, respectively. Saturation analysis using pooled substantia nigra demonstrated an almost complete loss of the high affinity component of the neurotensin receptor complex, yielding a 24% loss of the total binding capacity, with no alteration of the low affinity component. Similarly an important loss of binding was observed in monoiodo[125I-Tyr3]-Neurotensin autoradiograms of two substantia nigra from parkinsonian subjects. These results support the hypothesis of neurotensin receptors occurring on dopamine cell bodies and/or dendrites in human substantia nigra. Role of neurotensin may be of importance in the regulation of dopamine pathway involved in parkinsonism.

摘要

相似文献

1
Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects.
Biochem Biophys Res Commun. 1984 Nov 30;125(1):395-404. doi: 10.1016/s0006-291x(84)80381-2.
2
Parkinson's disease: depletion of substantia nigra neurotensin receptors.
Brain Res. 1984 Aug 6;308(1):186-90. doi: 10.1016/0006-8993(84)90935-1.
3
Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.大鼠黑质和腹侧被盖区中高亲和力125I-神经降压素结合位点与多巴胺能神经元之间的对应关系:放射自显影和免疫组织化学联合光镜研究
J Comp Neurol. 1989 Jan 1;279(1):128-37. doi: 10.1002/cne.902790111.
4
Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.大鼠脑中黑质纹状体和中脑边缘通路多巴胺能神经末梢上高亲和力神经降压素结合位点定位的放射自显影证据。
J Chem Neuroanat. 1989 Sep-Oct;2(5):253-7.
5
Morphological substrate for neurotensin-dopamine interactions in the rat midbrain tegmentum.大鼠中脑被盖区神经降压素-多巴胺相互作用的形态学基础。
Ann N Y Acad Sci. 1992;668:173-85. doi: 10.1111/j.1749-6632.1992.tb27349.x.
6
Characterization and visualization of neurotensin binding to receptor sites in human brain.神经降压素与人脑受体位点结合的特性与可视化
Biochem Biophys Res Commun. 1984 Apr 16;120(1):206-13. doi: 10.1016/0006-291x(84)91434-7.
7
Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra.长期使用抗精神病药物治疗可增强人和大鼠黑质中神经降压素受体的结合。
Nature. 1984;309(5966):350-2. doi: 10.1038/309350a0.
8
Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.对照和帕金森病大脑黑质及黑质旁核中表达神经降压素受体信使核糖核酸的黑素化神经元的异质性
Neuroscience. 1995 Jan;64(2):405-17. doi: 10.1016/0306-4522(94)00395-l.
9
Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.单侧纹状体内注射6-羟基多巴胺对[3H]神经降压素结合的双侧调节:来自受体放射自显影研究的证据。
Brain Res. 1991 Nov 8;564(1):37-44. doi: 10.1016/0006-8993(91)91349-6.
10
Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin.大鼠脑中神经降压素结合位点的分布:一项使用单碘[125I]酪氨酸3-神经降压素的光学显微镜放射自显影研究。
Neuroscience. 1987 Aug;22(2):525-36. doi: 10.1016/0306-4522(87)90350-2.

引用本文的文献

1
Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.两种新型神经降压素类似物对帕金森病大鼠模型的预防作用。
J Mol Neurosci. 2018 Dec;66(4):552-560. doi: 10.1007/s12031-018-1171-6. Epub 2018 Oct 30.
2
Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.在慢性6-羟基多巴胺损伤的大鼠中,多巴胺能神经元中神经营养因子的过表达会诱导突触前和突触后结构变化。
PLoS One. 2017 Nov 27;12(11):e0188239. doi: 10.1371/journal.pone.0188239. eCollection 2017.
3
Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.
神经降压素-多聚体介导的脑源性神经营养因子基因导入黑质多巴胺能神经元可预防早期帕金森病大鼠模型的黑质纹状体变性。
J Biomed Sci. 2015 Jul 22;22(1):59. doi: 10.1186/s12929-015-0166-7.
4
NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.NTS-聚集体:一种用于帕金森病神经保护治疗的潜在纳米载体。
Nanomedicine. 2012 Oct;8(7):1052-69. doi: 10.1016/j.nano.2012.02.009. Epub 2012 Mar 7.
5
The role of neurotensin in central nervous system pathophysiology: what is the evidence?神经降压素在中枢神经系统病理生理学中的作用:证据有哪些?
J Psychiatry Neurosci. 2006 Jul;31(4):229-45.
6
The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.纹状体神经降压素受体调节纹状体和苍白球谷氨酸及γ-氨基丁酸释放:通过苍白球-底丘脑核环路实现苍白球谷氨酸-γ-氨基丁酸相互作用的功能证据。
J Neurosci. 1998 Sep 1;18(17):6977-89. doi: 10.1523/JNEUROSCI.18-17-06977.1998.
7
Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.神经降压素通过神经元和胶质细胞受体的差异结合谱及内化过程
J Neurosci. 1997 Mar 1;17(5):1795-803. doi: 10.1523/JNEUROSCI.17-05-01795.1997.
8
Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects.精神分裂症患者和对照受试者内嗅皮质中神经降压素受体的放射自显影特征
J Neural Transm Gen Sect. 1995;102(1):55-65. doi: 10.1007/BF01276565.
9
Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.大鼠脑中存在可置换的非特异性[3H]神经降压素结合位点的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):400-5. doi: 10.1007/BF00500016.
10
Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.多巴胺能对大鼠大脑皮质边缘结构中125I标记的神经降压素结合位点密度的调控
Proc Natl Acad Sci U S A. 1986 Aug;83(16):6203-7. doi: 10.1073/pnas.83.16.6203.